Solid Biosciences Correlations
SLDB Stock | USD 4.78 0.18 3.91% |
The current 90-days correlation between Solid Biosciences LLC and Cullinan Oncology LLC is 0.3 (i.e., Weak diversification). The correlation of Solid Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Solid Biosciences Correlation With Market
Modest diversification
The correlation between Solid Biosciences LLC and DJI is 0.25 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Solid Biosciences LLC and DJI in the same portfolio, assuming nothing else is changed.
Solid |
Moving together with Solid Stock
0.69 | LUCD | Lucid Diagnostics | PairCorr |
0.68 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
0.62 | INTC | Intel Sell-off Trend | PairCorr |
0.67 | T | ATT Inc Sell-off Trend | PairCorr |
Moving against Solid Stock
0.65 | CMND | Clearmind Medicine Common | PairCorr |
0.62 | SCLX | Scilex Holding | PairCorr |
0.56 | MLSS | Milestone Scientific Earnings Call This Week | PairCorr |
0.54 | ASMB | Assembly Biosciences Earnings Call This Week | PairCorr |
0.34 | CDIOW | Cardio Diagnostics | PairCorr |
0.34 | ELVN | Enliven Therapeutics | PairCorr |
0.72 | CAT | Caterpillar | PairCorr |
0.61 | HD | Home Depot | PairCorr |
0.54 | MSFT | Microsoft Aggressive Push | PairCorr |
0.36 | BA | Boeing | PairCorr |
0.36 | DIS | Walt Disney | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Solid Stock performing well and Solid Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Solid Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
IPSC | 2.92 | (1.00) | 0.00 | (0.69) | 0.00 | 5.88 | 17.02 | |||
EWTX | 2.92 | (0.07) | 0.00 | (0.12) | 0.00 | 5.32 | 26.44 | |||
CCCC | 3.36 | (0.84) | 0.00 | (0.39) | 0.00 | 6.86 | 19.46 | |||
MLYS | 4.29 | 0.63 | 0.17 | (0.45) | 4.26 | 10.04 | 50.53 | |||
CGEM | 2.58 | (0.40) | 0.00 | (0.73) | 0.00 | 5.13 | 15.27 | |||
TCRR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
RVMD | 1.71 | (0.16) | 0.00 | (0.20) | 0.00 | 4.37 | 11.35 | |||
BDTX | 3.94 | (0.29) | 0.00 | (0.21) | 0.00 | 7.09 | 29.04 | |||
BCEL | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
PASG | 4.19 | (0.30) | 0.00 | (0.29) | 0.00 | 7.69 | 56.48 |
Solid Biosciences Corporate Executives
Elected by the shareholders, the Solid Biosciences' board of directors comprises two types of representatives: Solid Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Solid. The board's role is to monitor Solid Biosciences' management team and ensure that shareholders' interests are well served. Solid Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Solid Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.